Target intelligence / Profile preview

ARPC1A pseudogene 2 (ARPC1AP2)

Target
ARPC1AP2
Molecular classification
Other (pseudogene)
01

Overview

ARPC1A pseudogene 2 (ARPC1AP2) is a non-coding pseudogene, meaning it is a genomic sequence resembling the coding gene ARPC1A but lacks the capacity to produce a functional protein[1][2]. Pseudogenes are generally regarded as "non-functional" remnants of genes lost throughout evolution. However, accumulating evidence shows that some may regulate gene function via RNA-based mechanisms such as RNA interference or serving as microRNA decoys. There is no reported protein product, disease association, or drug interaction specific to ARPC1A pseudogene 2[1][2][3]. For the vast majority of pseudogenes, including ARPC1AP2, therapeutic targeting and biomarker roles are not established.

Other names
ARPC1AP2HGNC: 56495NCBI Gene: 204800Ensembl: ENSG00000268282
02

Biological functions

None established; as a pseudogene, it is not known to encode a functional protein. In general, pseudogenes may regulate gene expression through RNA mechanisms (such as acting as microRNA decoys or producing interfering RNAs), but no specific functions are reported for ARPC1AP2
03

Disease associations

None established for ARPC1AP2. Some pseudogenes participate in disease processes by regulating parent gene expression, but this has not been described for ARPC1AP2
04

Interacting drugs

None; pseudogenes are not typical drug targets

Beyond the preview

Go deeper on ARPC1A pseudogene 2 (ARPC1AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARPC1A pseudogene 2 (ARPC1AP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call